Rylaze 10 MG/0.5 ML vial 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FE2W0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,301
Award facts
- Contract value 100% obligated
- $34,301.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Rylaze 10 mg/0.5 ml vials with a ceiling value of $34,301.16 under a firm fixed price arrangement. This delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX, valued at $999,999,999.00 through December 2026), is scheduled for completion by September 17, 2025. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Rylaze is a specialty pharmaceutical product used in oncology treatment protocols, reflecting the company's role as a critical supplier of specialized medications to federal medical programs.
This award is part of AmerisourceBergen's extensive portfolio of pharmaceutical and medical supply deliveries to military and veteran healthcare systems. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen serves as a primary vendor through its global pharmaceutical support contract with DLA, supplying a comprehensive range of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. The Defense Logistics Agency is planning to establish the Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FE2W0?
SPE2DB25FE2W0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FE2W0 worth?
The government has obligated $34,301 on SPE2DB25FE2W0.
Is contract SPE2DB25FE2W0 an order under another contract?
Yes. SPE2DB25FE2W0 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE2W0 competed?
The extent of competition for SPE2DB25FE2W0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award